Insight Molecular Diagnostics annual operating margin
2020
2021
2022
2023
2024
2025
Insight Molecular Diagnostics Operating Margin Growth & History (IMDX)
Insight Molecular Diagnostics's operating margin was −1,260.76% for fiscal 2025.
View full Insight Molecular Diagnostics company overviewInsight Molecular Diagnostics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,260.76% | +1984.37 pp |
| 2024 | 2024-12-31 | −3,245.14% | −1572.75 pp |
| 2023 | 2023-12-31 | −1,672.39% | +206.21 pp |
| 2022 | 2022-12-31 | −1,878.60% | +565.67 pp |
| 2021 | 2021-12-31 | −2,444.27% | −0.93 pp |
| 2020 | 2020-12-31 | −2,443.34% | — |
Insight Molecular Diagnostics quarterly operating margin
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −4,770.71% | −2870.71 pp |
| Q1 2026 | 2026-03-31 | −13,790.63% | −13472.62 pp |
| Q4 2025 | 2025-12-31 | −2,057.51% | +205.41 pp |
| Q3 2025 | 2025-09-30 | −4,249.23% | +7502.94 pp |
| Q2 2025 | 2025-06-30 | −1,900.00% | +2553.85 pp |
| Q1 2025 | 2025-03-31 | −318.01% | +4947.33 pp |
| Q4 2024 | 2024-12-31 | −2,262.92% | +2889.63 pp |
| Q3 2024 | 2024-09-30 | −11,752.17% | −10233.99 pp |
| Q2 2024 | 2024-06-30 | −4,453.85% | −2662.49 pp |
| Q1 2024 | 2024-03-31 | −5,265.34% | −7235.04 pp |
| Q4 2023 | 2023-12-31 | −5,152.55% | −901.45 pp |
| Q3 2023 | 2023-09-30 | −1,518.18% | +1028.09 pp |
| Q2 2023 | 2023-06-30 | −1,791.36% | −1105.28 pp |
| Q1 2023 | 2023-03-31 | 1,969.70% | +2763.64 pp |
| Q4 2022 | 2022-12-31 | −4,251.09% | −2868.57 pp |
| Q3 2022 | 2022-09-30 | −2,546.27% | −1877.89 pp |
| Q2 2022 | 2022-06-30 | −686.08% | +324.60 pp |
| Q1 2022 | 2022-03-31 | −793.95% | +454.66 pp |
| Q3 2021 | 2021-09-30 | −1,382.52% | −257.48 pp |
| Q2 2021 | 2021-06-30 | −668.37% | +5463.09 pp |
| Q1 2021 | 2021-03-31 | −1,010.68% | +51683.07 pp |
| Q4 2020 | 2020-12-31 | −1,248.61% | — |
| Q3 2020 | 2020-09-30 | −1,125.05% | — |
| Q2 2020 | 2020-06-30 | −6,131.47% | — |
| Q1 2020 | 2020-03-31 | −52,693.75% | — |
Insight Molecular Diagnostics operating margin trends
Over the last five reported fiscal years, Insight Molecular Diagnostics's operating margin increased from −2,443.34% to −1,260.76%, a change of +1182.57 percentage points. The latest reported quarter, Q2 2026, shows −4,770.71%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Insight Molecular Diagnostics filings at SEC.gov ↗